{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:53:09Z","timestamp":1780696389675,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1038\/ng0196-97","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:06:39Z","timestamp":1092859599000},"page":"97-99","source":"Crossref","is-referenced-by-count":628,"title":["Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma"],"prefix":"10.1038","volume":"12","author":[{"given":"Lin","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa M.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Dracopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng019697_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0092-8674(93)90636-5","volume":"73","author":"CJ Sherr","year":"1993","unstructured":"Sherr, C.J. Mammalian G1 cyclins. cell. 73, 1059\u20131065 (1993).","journal-title":"cell."},{"key":"BFng019697_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature. 366, 704\u2013707 (1993).","journal-title":"Nature."},{"key":"BFng019697_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1126\/science.7809631","volume":"267","author":"M Serrano","year":"1995","unstructured":"Serrano, M., Gomez-Lahoz, E., DePinho, R., Beach, D. & Bar-Sagi, D. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science. 267, 249\u2013252 (1995).","journal-title":"Science."},{"key":"BFng019697_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon, G.J. & Beach, D. pl5INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature. 371, 257\u2013261 (1994).","journal-title":"Nature."},{"key":"BFng019697_CR5","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","volume":"8","author":"K-L Guan","year":"1994","unstructured":"Guan, K-L. et al. Growth suppression of p18, a P16INK4\/MTS1 and p14iNK4BMrs2_re|ated CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev. 8, 2939\u20132952 (1994).","journal-title":"Genes Dev."},{"key":"BFng019697_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian, C.J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15\u201321 (1994).","journal-title":"Nature Genet."},{"key":"BFng019697_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22\u201326 (1994).","journal-title":"Nature Genet."},{"key":"BFng019697_CR8","first-page":"2195","volume":"3","author":"C MacGeoch","year":"1994","unstructured":"MacGeoch, C. et al. Genetic heterogeneity in familial malignant melanoma Hum. Molec. Genet. 3, 2195\u20132200 (1994).","journal-title":"Molec. Genet."},{"key":"BFng019697_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ng0795-351","volume":"10","author":"NA Gruis","year":"1995","unstructured":"Gruis, N.A. et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet. 10, 351\u2013353 (1995).","journal-title":"Nature Genet."},{"key":"BFng019697_CR10","first-page":"5269","volume":"54","author":"M Ohta","year":"1994","unstructured":"Ohta, M. et al. Rarity of somatic and germline mutations of the cyclin dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 54, 5269\u20135272 (1994).","journal-title":"Cancer Res."},{"key":"BFng019697_CR11","first-page":"405","volume":"11","author":"L Liu","year":"1995","unstructured":"Liu, L. et al. .Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene. 11, 405\u2013412 (1995).","journal-title":"Oncogene."},{"key":"BFng019697_CR12","first-page":"1845","volume":"4","author":"GJ Walker","year":"1995","unstructured":"Walker, G.J. et al. .Mutations of the CDKN2\/ p16INK4 gene in Australian melanoma kindreds. Hum. Molec. Genet. 4, 1845\u20131852 (1995).","journal-title":"Genet."},{"key":"BFng019697_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.7652577","volume":"269","author":"T Wotfel","year":"1995","unstructured":"Wotfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269, 1281\u20131284 (1995).","journal-title":"Science."},{"key":"BFng019697_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan, L.M. et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363, 458\u2013460 (1993).","journal-title":"Nature."},{"key":"BFng019697_CR15","first-page":"851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller, H. et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Molec. Genet. 2, 851\u2013856 (1993).","journal-title":"Genet."},{"key":"BFng019697_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/367375a0","volume":"367","author":"RM Hofstra","year":"1994","unstructured":"Hofstra, R.M. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367, 375\u2013376 (1994).","journal-title":"Nature."},{"key":"BFng019697_CR17","first-page":"489","volume":"54","author":"AM Goldstein","year":"1994","unstructured":"Goldstein, A.M., Dracopoli, N.C., Engelstein, M., Fraser, M.C., Clark, W.H., & Tucker, M.A. Linkage of cutaneous malignant melanoma\/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am. J. Hum. Genet. 54, 489\u2013496 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng019697_CR18","first-page":"537","volume":"52","author":"AM Goldstein","year":"1993","unstructured":"Goldstein, A.M. et al. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM\/DN) on chromosome 1 p and evidence for genetic heterogeneity. Am. J. hum. Genet. 52, 537\u2013550 (1993).","journal-title":"Am. J. hum. Genet."},{"key":"BFng019697_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/ng0595-114","volume":"10","author":"K Ranade","year":"1995","unstructured":"Ranade, K. et al. Mutations associated with familial melanoma impair p16INK4 function. Nature Genet. 10, 114\u2013116 (1995).","journal-title":"Nature Genet."},{"key":"BFng019697_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1073\/pnas.84.2.388","volume":"84","author":"SK Hanks","year":"1987","unstructured":"Hanks, S.K. Homology probing: Identification of cDNA clones encoding members of the protein-serine kinase family. Proc. Natl. Acad. Sci. USA. 84, 388\u2013392 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BFng019697_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000133669","volume":"66","author":"DJ Demetrick","year":"1994","unstructured":"Demetrick, D.J., Zhang, H. & Beach, D.H. Chromosomal mapping of human CDK2, CDK4 and CDK6 cell cycle kinase genes. Cyfogenef. Cell Genet. 66, 72\u201374 (1994).","journal-title":"Cyfogenef. Cell Genet."},{"key":"BFng019697_CR22","first-page":"645","volume":"9","author":"JW Fountain","year":"1990","unstructured":"Fountain, J.W., Bale, S.J., Housman, D.E. & Dracopoli, N.C. Genetics of melanoma. Cancer Surv. 9, 645\u2013671 (1990).","journal-title":"Cancer Surv."},{"key":"BFng019697_CR23","first-page":"936","volume":"53","author":"DJ Nancarrow","year":"1993","unstructured":"Nancarrow, D.J. et al. Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet. 53, 936\u2013942 (1993).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng019697_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/hmg\/3.suppl_1.1487","volume":"3","author":"RW Laird","year":"1994","unstructured":"Laird, R.W, Jaenisch, R. DNA methylation and cancer. Hum. Molec. Genet. 3, 1487\u20131495 (1994).","journal-title":"Hum. Molec. Genet."},{"key":"BFng019697_CR25","first-page":"3375","volume":"9","author":"GA Otterson","year":"1994","unstructured":"Otterson, G.A., Kratzke, R.A., Coxon, A., Kirn, Y.W. & Kaye, F.J. Absence of p16iNK4 is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene. 9, 3375\u20133378 (1994).","journal-title":"Oncogene."},{"key":"BFng019697_CR26","first-page":"5535","volume":"53","author":"ZA Khatib","year":"1993","unstructured":"Khatib, Z.A. et al. Coamplification of the CDK4 gene with MDM2 and GLI. in human sarcomas.  Cancer Res. 53, 5535\u20135541 (1993).","journal-title":"Cancer Res."},{"key":"BFng019697_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/path.1711750209","volume":"175","author":"M Ladanyi","year":"1995","unstructured":"Ladanyi, M. et al. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J. Pathol. 175, 211\u2013217 (1995).","journal-title":"J. Pathol."},{"key":"BFng019697_CR28","first-page":"6321","volume":"54","author":"EE Schmidt","year":"1994","unstructured":"Schmidt, E.E., Ichimura, K., Reifenberger, G. & Collins, V.R. CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54, 6321\u20136324 (1994).","journal-title":"Cancer Res."},{"key":"BFng019697_CR29","first-page":"5804","volume":"54","author":"J He","year":"1994","unstructured":"He, J. et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res. 54, 5804\u20135807 (1994).","journal-title":"Cancer Res."},{"key":"BFng019697_CR30","unstructured":"Separation Technique File No.131: PCR-SSCP Analysis. Pharmacia Biotech, Alameda, Ca. (1995)."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0196-97","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0196-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0196-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:18:13Z","timestamp":1684441093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0196-97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BFng019697"],"URL":"https:\/\/doi.org\/10.1038\/ng0196-97","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}